NanoString Technologies, Inc. (NASDAQ:NSTG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Technologies, Inc. (the Company), upon recommendation from the
nominating and corporate governance committee of the Companys
board of directors, voted to appoint Elisha W. Finney, as a
director of the Company, effective immediately. Ms. Finney was
appointed as a Class II director with a term expiring at the
Companys 2018 annual meeting of stockholders. Ms. Finney was also
appointed to the audit committee of the Companys board of
directors and designated as an audit committee financial expert.
Ms. Finney (or any member of her immediate family) and the
Company (or any of its subsidiaries), and there is no arrangement
or understanding between Ms. Finney and any other person or
entity to which Ms. Finney was appointed as a director of the
Company.
plan for non-employee directors, including an initial stock
option grant, which was granted to Ms. Finney on May 9, 2017. The
standard compensation plan for non-employee directors is
described in the section entitled “Director Compensation
Program” of the Company’s definitive proxy statement on
Schedule 14A, filed with the Securities and Exchange Commission
on April 28, 2017.
of directors is attached hereto as Exhibit 99.1 and is
incorporated herein by reference.
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
NanoString Technologies, Inc. Press release dated May
10, 2017. |
About NanoString Technologies, Inc. (NASDAQ:NSTG)
NanoString Technologies, Inc. develops and manufactures intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company operates in the segment of development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. Its nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. It markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology, and to clinical laboratories and medical centers for diagnostic use. Its molecular diagnostic product Prosigna Breast Cancer Assay provides an assessment of a patient’s risk of recurrence for breast cancer. NanoString Technologies, Inc. (NASDAQ:NSTG) Recent Trading Information
NanoString Technologies, Inc. (NASDAQ:NSTG) closed its last trading session up +0.58 at 19.13 with 227,219 shares trading hands.
